Publication | Closed Access

Dose-reduction antiangiogenic curcumin-low molecular weight heparin nanodrugs for enhanced combinational antitumor therapy

NanomedicineOncologyMedicineNano-drug DeliveryPharmacotherapyTumor TargetingPharmacologyRadiation OncologyTumor Microenvironment